Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 1996

View Archived Issues

Novo Nordisk claims immunosuppressive serine palmitoyl transferase inhibitors

Clinical results with Seragen fusion toxin in psoriasis

Glaxo Wellcome claims 5alpha-reductase inhibitors for BPH

Hirudin-based thrombin inhibitors reported by Canadian investigators

ProCyte copper-based compound associated with improvement in ulcerative colitis

Growth stimulant reported by American Cyanamid

RPR claims taxoid antineoplastic compounds

ET antagonists revealed by SmithKline Beecham

EGFR tyrosine kinase inhibitors described by Pfizer

NIH awards grant for gene therapy approach to improving cancer treatment

Astra claims orally active peptide immunomodulators

FDA approves treatment for homocystinuria

New anti-HIV agents discovered by Hoechst

NO donors reported for cancer chemotherapy

Completion of phase IIa trials with CytoTAb in sepsis

Antineoplastic PTP inhibitors disclosed by Department of Health & Human Services

RCT reports novel circular oligonucleotides

Hycamtin approved in Europe

Mallinckrodt describes diagnostic agents for serotonin-related disorders

Cysteine protease inhibitors revealed by Takeda

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...